Benjamin Izar, Livnat Jerby, Aviv Regev, Asaf Rotem, Orit Rozenblatt-Rosen
The subject matter disclosed herein is generally directed to detecting and modulating novel gene signatures for the treatment and prognosis of cancer. The novel gene signatures predict overall survival in cancer and can be targeted therapeutically.